Durvalumab for patients who had mild radiation pneumonitis after concurrentchemoradiotherapy.
Not Applicable
- Conditions
- SCLC
- Registration Number
- JPRN-UMIN000036061
- Lead Sponsor
- Kobe city medical center general hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who do not meet the criteria above
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method